- T-Cell Leukemia Lymphoma Foundation | Seattle, WA

tcllfoundation.orgWebsite Profile

Title: T-Cell Leukemia Lymphoma Foundation | Seattle, WA
Keywords: T-Cell, Leukemia, Lymphoma, Foundation, Lymphoma education, cancer education, cancer resources, support tcll, tcllf, cancer research, suppot the foundation, non-profit organization, cancer support, t...
Description:The T-Cell Leukemia Lymphoma Foundation is a non-profit organization that was formed in an effort to fulfill several purposes. is ranked 25408406 in the world (amongst the 40 million domains). A low-numbered rank means that this website gets lots of visitors. This site is relatively popular among users in the united states. It gets 50% of its traffic from the united states .This site is estimated to be worth $2,503. This site has a low Pagerank(0/10). It has 1 backlinks. has 43% seo score. Information

Website /
Website IP Address:
Domain DNS, ranks

Alexa Rank:6197371
EveryoneDomain Rank:2
Google Page Rank:0/10 (Google Pagerank Has Been Closed) Traffic & Earnings

Purchase/Sale Value:$3,352
Daily Revenue:$9
Monthly Revenue:$275
Yearly Revenue:$$3,352
Daily Unique Visitors:845
Monthly Unique Visitors:25,350
Yearly Unique Visitors:308,425 WebSite Httpheader

StatusCode 200
Vary Accept-Encoding
Cache-Control no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Server Apache
Connection close
Transfer-Encoding chunked
Content-Type text/html; charset=utf-8
Date Tue, 25 Sep 2018 14:45:25 GMT WebSite Httpheader

Keyword Count Percentage
T-Cell 18 1.57%
Leukemia 3 0.34%
Lymphoma 22 2.58%
Foundation 1 0.14%
Lymphoma education 0 0.00%
cancer education 0 0.00%
cancer resources 0 0.00%
support tcll 3 0.52%
tcllf 5 0.36%
cancer research 0 0.00%
suppot the foundation 0 0.00%
non-profit organization 0 0.00%
cancer support 0 0.00%
t... 0 0.00% Similar Website

Domain WebSite Title Leukemia & Lymphoma Foundation | Online Information about Leukemia & Lymphoma | Hairy Cell Leukemia Foundation T-cell Lymphoma Forum Blood Cancer Support | Lymphoma & Leukemia | Med City Foundation THE CHARLES ERROL NICHOLS LEUKEMIA & LYMPHOMA FOUNDATION AND SCHOLARSHIP FUND Page 1 - I was finally diagnosed with hairy cell leukemia Lymphoma HCL in Iran - Stem Cell Research... Lymphoma Leukemia Cancer Leukemia & Lymphoma Society - Home Home — Leukemia Lymphoma Society Team T Foundation | For Leukemia Awareness Folotyn | Relapsed or Refractory Peripheral T-Cell Lymphoma Focus on Peripheral T-Cell Lymphoma | PTCL Team In Training | Leukemia & Lymphoma Society Light The Night | Leukemia & Lymphoma Society Leukemia & Lymphoma Society | Donate Today! Leukemia & Lymphoma Society | Donate Today! Leukemia & Lymphoma Society | Donate Today! Leukemia & Lymphoma Society | Donate Today! Alexa Rank History Chart aleax Html To Plain Text

T-Cell Leukemia Lymphoma Foundation | Seattle, WA About TCLLF Contact Us Join our mailing list. View Cart For Patients For Medical Providers Resources & Support Clinical Trials Get Involved Support TCLLF For Patients For Medical Providers Resources & Support Clinical Trials Get Involved Support TCLLF Solving the T-Cell puzzle together, one piece at a time Become a Sponsor Previous Next Upcoming Events Upcoming Events TCLLF hosts a variety of events, ranging from patient education forums to fundraisers. Check to see what upcoming events may interest or benefit you. View Upcoming Events > Find Resources & Support Find Resources & Support T-cell patients, family members and caregivers have a lot on their minds and shoulders. Visit our resources & support page for information to make their journey a little easier. Browse Resources > Clinical Trials Explore Research View current clinical trials available for PTCL & CTCL patients Search current clinical trials and get access to exciting new advances in T-cell research. View Clinical Trials > Get Involved Get Involved Inquire about ways YOU can get involved by volunteering or planning your own fundraising event to support TCLLF. View Events Calendar > Who We Are Sponsors A Big THANK YOU To Our 2016 Sponsors! Platinum Sponsors Charles Beeler - Los Altos, CA Seth & Lauren Rand - Parkland, FL Tina A. Ross - Marysville, WA To become a Platinum Sponsor - or donate - click HERE Upcoming Events Find Resources & Support Clinical Trials Get Involved Who We Are Sponsors Understanding T-Cell Leukemia Lymphoma What is TCLL? What if I have TCLL? About TCLL Therapy What is TCLL? Lymph nodes are comprised of both T-cells and B-cells of the immune system that, under normal circumstances, function together to fight off infection or rid the body of cancer. Due to breakdowns in the immune cells (caused by mutations or environment), they can transform and become malignant or cancerous. Depending on which cell transforms, doctors recognize B-cell or T-cell lymphomas — both are non-Hodgkin type. T-cell lymphomas are a family of aggressive (fast growing) lymph node cancers that originate from an immune T-cell. T-cell lymphomas are rare; for every person diagnosed with T-cell lymphoma, there are 10 diagnosed with B-cell lymphoma. Under the name of T-cell lymphoma, or PTCL, hide 12 different subtypes. Therefore, each case of PTCL is uncommon; some of the subtypes are exceedingly rare and require special attention. The subtypes of PTCL most commonly diagnosed in the United States are peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), angioimmunoblastic T-cell lymphoma (AITL), anaplastic large cell lymphoma (ALCL), and T-cell prolymphocytic leukemia (T-PLL). What if I have, or know someone who has TCLL? If you or one of your loved ones are diagnosed with one of the subtypes of TCLL, the first priority is to obtain a referral to a local oncologist for a comprehensive diagnostic work-up. Before any treatments are considered, several steps need to be completed. First, the diagnosis has to be confirmed by a qualified pathologist who has knowledge in lymphomas. In general, community pathologists in the United States are quite skilled in making the correct diagnosis by using sophisticated tests. Occasionally, referrals to academic centers are made in order for a specialty pathologist to get a “second look.” Second, it is important to complete a staging work-up in order to find out how extensively the lymphoma has spread through the body; this is accomplished by a combination of CT scan and PET scan technologies. In addition, a bone marrow biopsy is performed by the oncologist or pathologist to find out whether the lymphoma extended into this body compartment. Third, your physician will determine the “risk of the disease” by putting together the information from the prior steps with additional blood tests; something doctors call “risk-stratification”. This last step is important in deciding on initial therapy and a long-term plan. Given the rarity of PTCL, it is advisable to ask your oncologist for a referral to obtain a second opinion consultation from one of the recognized national experts in T-cell lymphomas that could be within reasonable travel distance from your home. Once the steps above are completed and you and your family have obtained education about your disease (i.e., treatment planning and discussion of possible side effects and risks of chemotherapy), your oncologist will begin treatment. About TCLL Therapy Once the diagnosis of T-cell lymphoma is confirmed and your physician has performed all of the staging, your doctor will choose the most appropriate therapy for you. While treatments can vary depending on the subtype of lymphoma, in most situations patients will receive multi-agent chemotherapy (several chemotherapeutic administered concurrently or sequentially). Treatment is given in cycles; usually every three weeks. Patients with early stage (stage I-II) disease will generally receive 3-4 cycles of chemotherapy (2-3 months), while patients with advanced stage disease (stage III-IV) will generally receive 6-8 cycles of chemotherapy (5-6 months). In addition to chemotherapy, patients with early stage disease will also receive radiation treatment to the area of their disease (i.e., neck, groin, armpit area, etc…). After treatment is completed your oncologist will order a new PET-CT scan to confirm that the lymphoma is in remission (no visible evidence of disease). You will subsequently be followed with CT scans 2-4 times a year for up to 5 years, to ensure that the lymphoma did not return. After 5 years, remission is generally considered permanent (i.e., you are cured of lymphoma). If your physician deems your lymphoma “high-risk” at the time of diagnosis, he or she may refer you for consultation to consider a bone marrow transplant in your first remission. A transplant oncologist will discuss all details, including the risks and benefits of the bone marrow transplantation, with you. If the lymphoma should return after initial remission or if remission is never achieved with first therapy, it is called relapsed or refractory disease. Patients with relapsed or refractory PTCL can still be cured, but it requires more intense chemotherapy regimens, and bone marrow transplantation is mandatory once remission is achieved. At any time during the course of PTCL (initial diagnosis or relapsed/refractory disease), it is always worthwhile to consider participation in clinical trials of new chemotherapy or biologic drugs. You might receive superior and more effective treatment on a clinical trial that would not be available for general use for a number of years. ASK YOUR ONCOLOGIST OR VIEW OUR CLINICAL TRIALS PAGE FOR MORE INFORMATION. Learning Corner Featuring monthly mini-educational sessions on different types of T-Cell cancers Learn More > Be a part of something life changing. Learn how your donation can impact the lives of those affe... Whois

Registry Domain ID: D168936500-LROR
Registrar WHOIS Server:
Registrar URL:
Updated Date: 2015-06-10T21:08:03Z
Creation Date: 2013-06-12T04:01:36Z
Registry Expiry Date: 2017-06-12T04:01:36Z
Registrar Registration Expiration Date:
Registrar:, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited
Domain Status: clientRenewProhibited
Domain Status: clientTransferProhibited
Domain Status: clientUpdateProhibited
Registry Registrant ID: C138971541-LROR
Registrant Name: ANDREI SHUSTOV
Registrant Organization: T-Cell Leukemia Lymphoma Foundation
Registrant Street: 7020 168th St SW
Registrant City: Lynnwood
Registrant State/Province: Washington
Registrant Postal Code: 98037
Registrant Country: US
Registrant Phone: +1.2066181299
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email:
Registry Admin ID: C138971543-LROR
Admin Organization: T-Cell Leukemia Lymphoma Foundation
Admin Street: 7020 168th St SW
Admin City: Lynnwood
Admin State/Province: Washington
Admin Postal Code: 98037
Admin Country: US
Admin Phone: +1.2066181299
Admin Phone Ext:
Admin Fax:
Admin Fax Ext:
Admin Email:
Registry Tech ID: C138971542-LROR
Tech Organization: T-Cell Leukemia Lymphoma Foundation
Tech Street: 7020 168th St SW
Tech City: Lynnwood
Tech State/Province: Washington
Tech Postal Code: 98037
Tech Country: US
Tech Phone: +1.2066181299
Tech Phone Ext:
Tech Fax:
Tech Fax Ext:
Tech Email:
DNSSEC: unsigned
>>> Last update of WHOIS database: 2018-09-25T14:45:25Z

The data contained in, LLC's WhoIs database,
while believed by the company to be reliable, is provided "as is"
with no guarantee or warranties regarding its accuracy. This
information is provided for the sole purpose of assisting you
in obtaining information about domain name registration records.
Any use of this data for any other purpose is expressly forbidden without the prior written
permission of, LLC.By submitting an inquiry,
you agree to these terms of usage and limitations of warranty.In particular,
you agree not to use this data to allow, enable, or otherwise make possible,
dissemination or collection of this data, in part or in its entirety, for any
purpose, such as the transmission of unsolicited advertising and
and solicitations of any kind, including spam.You further agree
not to use this data to enable high volume, automated or robotic electronic
processes designed to collect or compile this data for any purpose,
including mining this data for your own personal or commercial purposes.

Please note: the registrant of the domain name is specified
in the "registrant" section.In most cases,, LLC
is not the registrant of domain names listed in this database.";

For more information on Whois status codes, please visit